AJP - Endo Journal of Neurophysiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 294: E157-E167, 2008. First published October 30, 2007; doi:10.1152/ajpendo.00615.2006
0193-1849/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/1/E157    most recent
00615.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bonaventura, M. M.
Right arrow Articles by Lux-Lantos, V. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bonaventura, M. M.
Right arrow Articles by Lux-Lantos, V. A.

GABAB receptors and glucose homeostasis: evaluation in GABAB receptor knockout mice

M. M. Bonaventura,1 P. N. Catalano,1,2 A. Chamson-Reig,3 E. Arany,3 D. Hill,3 B. Bettler,4 F. Saravia,1,2 C. Libertun,1,2 and V. A. Lux-Lantos1

1Instituto de Biología y Medicina Experimental-Consejo Nacional de Investigaciones Científicas y Técnicas; 2Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina; 3Lawson Health Research Institute, St. Joseph's Health Care, London, Ontario, Canada; and 4Department of Biomedicine, University of Basel, Basel, Switzerland

Submitted 16 November 2006 ; accepted in final form 22 October 2007

GABA has been proposed to inhibit insulin secretion through GABAB receptors (GABABRs) in pancreatic β-cells. We investigated whether GABABRs participated in the regulation of glucose homeostasis in vivo. The animals used in this study were adult male and female BALB/C mice, mice deficient in the GABAB1 subunit of the GABABR (GABAB–/–), and wild types (WT). Blood glucose was measured under fasting/fed conditions and in glucose tolerance tests (GTTs) with a Lifescan Glucose meter, and serum insulin was measured by ELISA. Pancreatic insulin content and islet insulin were released by RIA. Western blots for the GABAB1 subunit in islet membranes and immunohistochemistry for insulin and GABAB1 were performed in both genotypes. BALB/C mice preinjected with Baclofen (GABABR agonist, 7.5 mg/kg ip) presented impaired GTTs and decreased insulin secretion compared with saline-preinjected controls. GABAB–/– mice showed fasting and fed glucose levels similar to WT. GABAB–/– mice showed improved GTTs at moderate glucose overloads (2 g/kg). Baclofen pretreatment did not modify GTTs in GABAB–/– mice, whereas it impaired normal glycemia reinstatement in WT. Baclofen inhibited glucose-stimulated insulin secretion in WT isolated islets but was without effect in GABAB–/– islets. In GABAB–/– males, pancreatic insulin content was increased, basal and glucose-stimulated insulin secretion were augmented, and impaired insulin tolerance test and increased homeostatic model assessment of insulin resistance index were determined. Immunohistochemistry for insulin demonstrated an increase of very large islets in GABAB–/– males. Results demonstrate that GABABRs are involved in the regulation of glucose homeostasis in vivo and that the constitutive absence of GABABRs induces alterations in pancreatic histology, physiology, and insulin resistance.

{gamma}-aminobutyric acid; insulin; glycemia; pancreas histology



Address for reprint requests and other correspondence: V. A. Lux-Lantos, V. de Obligado 2490, (C1428ADN) Buenos Aires, Argentina (e-mail: vlux{at}dna.uba.ar)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.